Trial Profile
A Randomized, Double-blind, Placebo-controlled Examination of the Effects of Tolcapone (TASMAR) on Vigilance in Healthy Volunteers After Sleep Deprivation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tolcapone (Primary)
- Indications Sleep deprivation
- Focus Therapeutic Use
- 11 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2014 New trial record